DMAAR Drugs Made In America Acquisition Corp. - Rights

NAS · US · Financial Services · Diversified Financial Services

0.1250USD-1.03%Mkt Cap: —P/E: —6d ago

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business …

Industry Peers

Diversified Financial Services

Screen all

FACT

FACT II Acquisition Corp

$260.73MUSDP/E 67.0

BPAC

Blueport Acquisition Ltd

$75.55MUSDP/E 255.8

ROC

Rank One Computing Corporation

$71.17MUSD

APLMW

Apollomics Inc. - Warrant

$32.34MUSD

KAC-P

Kalon Acquisition Corp.

$157.0KUSD

SKYAW

SkyAI, Inc. - Warrant

—

BIDWR

Tribeca Strategic Acquisition Corp. - Rights

—

RDACR

Rising Dragon Acquisition Corp. - Rights

—

SPCM

Tradr 2X Long SpaceX Daily ETF

—

DSACW

Daedalus Special Acquisition Corp. - Warrant

Bluerock Acquisition Corp. - Warrants

—

PECEW

Peace Acquisition Corp - Warrant

—

CRGOW

Freightos Limited - Warrants

—

ALPXW

Alpex Acquisition Corporation - Warrants

—

BENFW

Beneficient - Warrant

—

CATLR

Catalyst Acquisition Corp. - Rights

Murano Global Investments PLC - Warrants

—

AMACW

AMR Resources Acquisition Corp - Warrants

—

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)6.09M USD

Revenue/Share—

Last Price0.1250 USD

Fiscal Year End—

MR Quarter—

Employees—

CountryUS

SectorFinancial Services

IndustryDiversified Financial Services

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-0.41

EPS (TTM)—

EPS (Forward)—

52W Range

0.081637% of range0.2000

52W High0.2000 USD

52W Low0.0816 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE—

ROA—

Growth

Revenue Growth—

Earnings Growth-17.90%

Cash Flow & Leverage

Operating CF-517.14K USD

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt329.72K USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio0.02

Quick Ratio0.01

Book Value/Sh-0.30 USD

Cash/Share0.0010 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.20.40M

Float19.79M

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta—

S&P 52W Chg15.78%

Avg Vol (30d)35.27K

Avg Vol (10d)—

Technical Indicators

RSI (14)45.0

MACD-0.0053

MACD Signal-0.0047

MACD Hist.-0.0006

BB Upper0.1586 USD

BB Middle0.1339 USD

BB Lower0.1092 USD

BB Width36.90%

ATR (14)0.0139 USD

Vol Ratio (20d)0.33x